Louis Moore Bacon's AVNS Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 88,259 shares of Avanos Medical, Inc. (AVNS) worth $1.02 M, representing 0.01% of the portfolio. First purchased in 2024-Q4, this short-term holding has been held for 4 quarters.
Based on 13F filings, Louis Moore Bacon has maintained this position in AVNS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 34,812 shares. Largest reduction occurred in Q2 2025, reducing 7,840 shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Avanos Medical (AVNS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Avanos Medical (AVNS) Trades by Louis Moore Bacon
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2024 | +37,070 | New Buy | 37,070 | $15.92 |
| Q1 2025 | +24,217 | Add 65.33% | 61,287 | $14.33 |
| Q2 2025 | -7,840 | Reduce 12.79% | 53,447 | $12.24 |
| Q3 2025 | +34,812 | Add 65.13% | 88,259 | $11.56 |
Louis Moore Bacon's Avanos Medical Investment FAQs
Louis Moore Bacon first purchased Avanos Medical, Inc. (AVNS) in Q4 2024, acquiring 37,070 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Avanos Medical, Inc. (AVNS) for 4 quarters since Q4 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon's largest addition to Avanos Medical, Inc. (AVNS) was in Q4 2024, adding 37,070 shares worth $590,154. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 88,259 shares of Avanos Medical, Inc. (AVNS), valued at approximately $1.02 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Avanos Medical, Inc. (AVNS) represents approximately 0.01% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon's peak holding in Avanos Medical, Inc. (AVNS) was 88,259 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.